186 related articles for article (PubMed ID: 5768100)
1. Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro.
Carlsson A; Fuxe K; Hamberger B; Malmfors T
Br J Pharmacol; 1969 May; 36(1):18-28. PubMed ID: 5768100
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.
Arnt J; Christensen AV; Hyttel J
Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):101-7. PubMed ID: 2409454
[TBL] [Abstract][Full Text] [Related]
3. [Histochemical study of the effect of drugs on the uptake of alpha-methylnoradrenaline by noradrenaline and dopamine containing neurones in rats treated with reserpine].
Lorez HP
Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(3):241-60. PubMed ID: 5358460
[No Abstract] [Full Text] [Related]
4. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
Hyttel J
Psychopharmacology (Berl); 1977 Mar; 51(3):225-33. PubMed ID: 403537
[TBL] [Abstract][Full Text] [Related]
5. Activation and desensitization of presynaptic alpha 2-adrenoceptors after inhibition of neuronal uptake by antidepressant drugs in the rat vas deferens.
García-Sevilla JA; Zubieta JK
Br J Pharmacol; 1986 Dec; 89(4):673-83. PubMed ID: 3028549
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin.
Hyttel J; Larsen JJ
J Neurochem; 1985 May; 44(5):1615-22. PubMed ID: 2580950
[TBL] [Abstract][Full Text] [Related]
7. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.
Pawlowski L; Nowak G; Górka Z; Mazela H
Psychopharmacology (Berl); 1985; 86(1-2):156-63. PubMed ID: 3927352
[TBL] [Abstract][Full Text] [Related]
8. The effect of mepiprazole on central monoamine neurons. Evidence for increased 5-hydroxytryptamine and dopamine receptor activity.
Fuxe K; Agnati LF; Ungerstedt U
Eur J Pharmacol; 1976 Jan; 35(1):93-108. PubMed ID: 943291
[TBL] [Abstract][Full Text] [Related]
9. Uptake of monoamines into central neurones and the blood-brain barrier in the infant rat.
Loizou LA
Br J Pharmacol; 1970 Dec; 40(4):800-13. PubMed ID: 5495178
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties.
Christensen AV; Fjalland B; Pedersen V; Danneskiold-Samsoe P; Svendsen O
Eur J Pharmacol; 1977 Jan; 41(2):153-62. PubMed ID: 12988
[TBL] [Abstract][Full Text] [Related]
11. Brain tissue transplanted to the anterior chamber of the eye. 4. Drug-modulated transmitter release in central monoamine nerve terminals lacking normal postsynaptic receptors.
Seiger A; Olson L; Farnebo LO
Cell Tissue Res; 1976 Jan; 165(2):157-70. PubMed ID: 174817
[TBL] [Abstract][Full Text] [Related]
12. Functional properties of the uptake of amines in immortalised peptidergic neurones (transport-P).
Al-Damluji S; Kopin IJ
Br J Pharmacol; 1996 Jan; 117(1):111-8. PubMed ID: 8825351
[TBL] [Abstract][Full Text] [Related]
13. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.
Lippman W; Pugsley TA
Can J Physiol Pharmacol; 1976 Aug; 54(4):494-509. PubMed ID: 974878
[TBL] [Abstract][Full Text] [Related]
14. Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation.
Corrodi H; Farnebo LO; Fuxe K; Hamberger B
Eur J Pharmacol; 1975 Feb; 30(2):172-81. PubMed ID: 1173234
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced release of biogenic amines from synaptosomes and blood platelets of guinea-pigs.
Peyer M; Pletscher A; Affolter H
Neuropharmacology; 1982 Sep; 21(9):831-8. PubMed ID: 6216418
[TBL] [Abstract][Full Text] [Related]
16. Effects of prenatal methylazoxymethanol treatment on the development of central monoamine neurons.
Jonsson G; Hallman H
Brain Res; 1981 Nov; 254(4):513-30. PubMed ID: 6118203
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical properties of 3,3-dimethyl-1-[3-(methylamino) propyl]-1-phenylindan HCl (LU 3-049) and selected tricyclic antidepressants.
Salama AI; Goldberg ME
Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):317-29. PubMed ID: 849078
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of presynaptic components (uptake--release) in antidepressants].
Dolzhenko AT
Farmakol Toksikol; 1984; 47(5):22-5. PubMed ID: 6094236
[TBL] [Abstract][Full Text] [Related]
19. Effect of neuroleptics and other drugs on monoamine uptake by membranes of adrenal chromaffin granules.
Pletscher A
Br J Pharmacol; 1977 Mar; 59(3):419-24. PubMed ID: 584682
[TBL] [Abstract][Full Text] [Related]
20. DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.
Jonsson G; Hallman H; Ponzio F; Ross S
Eur J Pharmacol; 1981 Jun; 72(2-3):173-88. PubMed ID: 6265244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
